{"nct_id":"NCT00441103","title":"A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2014-06","start_date":"2006-12","start_date_type":null,"primary_completion_date":"2008-11","primary_completion_date_type":"ACTUAL","completion_date":"2009-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}